Skip to main content
To the Editor: Punding is a stereotyped behavior characterized by intense fascination with complex, excessive, non–goal-oriented, and repetitive activity, such as manipulation of technical equipment; handling, examining, or sorting through common objects; grooming; hoarding; and engagement in extended monologues devoid of content.1 Patients’ awareness of punding might be poor, therefore underreporting it.2 The most common causes of punding currently are dopaminergic replacement therapy in patients with Parkinson’s disease and cocaine/amphetamine use.1

Case Report

The present case concerned a 64-year-old woman, who was unemployed and diagnosed with bipolar disorder type I at age 25, according to DSM-IV-TR criteria. She also reported several manic/mixed episodes, during which she developed impulsive compulsive behaviors (i.e., pathological shopping).3 She was admitted to the psychiatric ward of the clinic because of the persistence of a severe mixed state. On admission, the patient underwent thorough psychiatric, medical, and physical examination. Her father was diagnosed with Parkinson’s disease.
On admission, she had been taking quetiapine 200 mg/day, alprazolam 1.5 mg/day, and clotiapine 20 mg/day for 6 months. She had recently discontinued sertraline. She was experiencing a mixed state, characterized by dysphoria, irritability, less need for sleep, racing thoughts and speech, overactivity, and suicidal ideation. The patient reported lavish spending and severe debts. The patient’s daughter reported that she spent most of her day tying scarves. The patient actually continuously purchased numerous scarves and stored them in plastic bags. Daily these scarves were repeatedly folded along oblique lines, knotted, or jointed, without a purpose. When asked about this behavior, she responded with denial and minimization. Throughout her hospitalization, she was repeatedly observed fiddling with a glove over and over again and continued to spend most of her day folding scarves. The onset of this behavior was reported to be 3 years ago, and no association with psychopharmacological treatments was observed. No change in the severity of the behavior was reported after the administration of quetiapine4 and clotiapine. To exclude an association between the occurrence of punding and a possible Parkinson’s disease diagnosis, the patient underwent a thorough neurological examination, which ruled out signs of parkinsonism; in addition, she was not under treatment with dopaminergic agents.
The patient was administered the Punding Rating Scale1; item 1, specific for PD patients/addicts and relative to dopaminergic medication, was modified. The patient was followed up for 1 year and assessed at T0 (baseline), T1 (3 months), T2 (6 months), and T3 (12 months). Table 1 shows the scores the patient obtained at baseline and during follow-up. During the follow-up, punding behaviors did not vary in relation to pharmacological treatments, and no changes were observed across the different mood phases.
TABLE 1. Psychiatric Assessment and Punding Rating Scale1 at Baseline and Follow-Up
 T0 (baseline)T1 (3 months)T2 (6 months)T3 (12 months)
Phase of illnessMixed stateEuthymiaEuthymiaDepression
Brief Psychiatric Rating Scale56454247
Global Assessment of Functioning35505540
Young Mania Rating Scale19430
Hamilton Depression Rating Scale166416
Punding Rating Scale124222321
Pharmacological treatment (mg)Quetiapine (200)Quetiapine (300)Quetiapine (200)Quetiapine (200)
Alprazolam (1.5)Valproate (900)Valproate (900)Valproate (900)
Clotiapine (20)Alprazolam (0.75)Alprazolam (0.75)Alprazolam (1.25)

Discussion

This case suggests that punding may occur during the course of bipolar disorder. A case report cannot quantify a clinical association. Specific studies are needed to investigate the real proportions of punding behaviors in bipolar disorder and to clarify the pathophysiology and possible treatment strategies5 for this condition.

References

1.
Fasano A, Petrovic I: Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 2010; 15:560–573
2.
Fasano A, Pettorruso M, Ricciardi L, et al: Punding in Parkinson’s disease: the impact of patient’s awareness on diagnosis. Mov Disord 2010; 25:1297–1299
3.
Di Nicola M, Tedeschi D, Mazza M, et al: Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions. J Affect Disord 2010; 125:82–88
4.
Miwa H, Morita S, Nakanishi I, et al: Stereotyped behaviors or punding after quetiapine administration in Parkinson’s disease. Parkinsonism Relat Disord 2004; 10:177–180
5.
Fasano A, Ricciardi L, Pettorruso M, et al: Management of punding in Parkinson’s disease: an open-label prospective study. J Neurol 2011; 258:656–660

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E8 - E9
PubMed: 26037886

History

Published online: 1 January 2014
Published in print: Fall 2014

Authors

Affiliations

Mauro Pettorruso, M.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Marco Di Nicola, M.D., Ph.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Luisa De Risio, M.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Alfonso Fasano, M.D., Ph.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Giovanni Martinotti, M.D., Ph.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Gianluigi Conte, M.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Anna Rita Bentivoglio, M.D., Ph.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)
Luigi Janiri, M.D.
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy (MP, MDN, LDR, GC, LJ); Movement Disorders Center, Toronto Western Hospital, Krembil Neurosciences Program, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (AF); Department of Neurosciences and Imaging, University “G. D'Annunzio”, Chieti, Italy (GM); and Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy (ARB)

Notes

Correspondence: Mauro Pettorruso; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share